Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 5/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 4/20 | 0.35 |
| ▸ | RELA | Q04206 | 4/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | XBP1 | P17861 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.32 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.32 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 4/20 | 0.31 |
| ▸ | CA9 | Q16790 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2951827 | 1.00 | NLRP3 (0.55) | NLRP3NFKB1NFKB2RELACA1 | |
| SCHEMBL10571332 | 0.83 | NLRP3 (0.45) | NLRP3NFKB1NFKB2RELAMAPT | |
| SCHEMBL14634399 | 0.81 | NLRP3 (0.48) | NLRP3NFKB1NFKB2RELA | |
| SCHEMBL14634400 | 0.81 | NLRP3 (0.48) | NLRP3NFKB1NFKB2RELA | |
| SCHEMBL10573770 | 0.81 | NLRP3 (0.44) | NLRP3NFKB1NFKB2RELA | |
| SCHEMBL10568146 | 0.79 | NLRP3 (0.46) | NLRP3NFKB1NFKB2RELA | |
| SCHEMBL10567633 | 0.79 | NLRP3 (0.49) | NLRP3NFKB1NFKB2RELAMAPT | |
| SCHEMBL28773473 | 0.78 | NLRP3 (0.35) | NLRP3 | |
| SCHEMBL6993914 | 0.77 | — | — | |
| SCHEMBL14634328 | 0.76 | KMT2A (0.44) | NLRP3NFKB1NFKB2RELAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2228373-B1 | METHOD FOR PRODUCING 4'-ETHYNYL d4T | ONCOLYS BIOPHARMA INC (JP) | 2017-02-08 | — | — | EP | disclosed |
| EP-2228373-B1 | METHOD FOR PRODUCING 4'-ETHYNYL d4T | ONCOLYS BIOPHARMA INC (JP) | 2017-02-08 | — | — | EP | disclosed |
| EP-2537839-B1 | B-DIHYDROFURAN DERIVING COMPOUND, METHOD FOR PRODUCING B-DIHYDROFURAN DERIVING COMPOUND OR B-TETRAHYDROFURAN DERIVING COMPOUND, B -GLYCOSIDE COMPOUND, METHOD FOR PRODUCING B-GLYCOSIDE COMPOUND, AND METHOD FOR PRODUCING 4'-ETHYNYL D4T AND ANALOGUE COMPOUNDS THEREOF | NISSAN CHEMICAL IND LTD (JP) | 2016-12-14 | — | — | EP | disclosed |
| EP-2537839-B1 | B-DIHYDROFURAN DERIVING COMPOUND, METHOD FOR PRODUCING B-DIHYDROFURAN DERIVING COMPOUND OR B-TETRAHYDROFURAN DERIVING COMPOUND, B -GLYCOSIDE COMPOUND, METHOD FOR PRODUCING B-GLYCOSIDE COMPOUND, AND METHOD FOR PRODUCING 4'-ETHYNYL D4T AND ANALOGUE COMPOUNDS THEREOF | NISSAN CHEMICAL IND LTD (JP) | 2016-12-14 | — | — | EP | disclosed |
| US-9212174-B2 | Certain β-dihydrofuran derivatives | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-12-15 | — | — | US | disclosed |
| US-9212174-B2 | Certain β-dihydrofuran derivatives | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-12-15 | — | — | US | disclosed |
| EP-2537851-B1 | PROCESS FOR PREPARATION OF B-GLYCOSIDE COMPOUNDS | NISSAN CHEMICAL IND LTD (JP) | 2015-06-10 | — | — | EP | disclosed |
| US-9051288-B2 | Method for producing 4′-ethynyl d4T | ONCOLYS BIOPHARMA, INC. (JP) | 2015-06-09 | — | — | US | disclosed |
| US-9051288-B2 | Method for producing 4′-ethynyl d4T | ONCOLYS BIOPHARMA, INC. (JP) | 2015-06-09 | — | — | US | disclosed |
| US-8975394-B2 | Process for preparation of β-glycoside compounds | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-03-10 | — | — | US | disclosed |
| EP-2537839-A1 | B-DIHYDROFURAN DERIVING COMPOUND, METHOD FOR PRODUCING B-DIHYDROFURAN DERIVING COMPOUND OR B-TETRAHYDROFURAN DERIVING COMPOUND, B -GLYCOSIDE COMPOUND, METHOD FOR PRODUCING B-GLYCOSIDE COMPOUND, AND METHOD FOR PRODUCING 4'-ETHYNYL D4T AND ANALOGUE COMPOUNDS THEREOF | Nissan Chemical Industries, Ltd. (JP) | 2012-12-26 | — | — | EP | disclosed |
| EP-2537839-A1 | B-DIHYDROFURAN DERIVING COMPOUND, METHOD FOR PRODUCING B-DIHYDROFURAN DERIVING COMPOUND OR B-TETRAHYDROFURAN DERIVING COMPOUND, B -GLYCOSIDE COMPOUND, METHOD FOR PRODUCING B-GLYCOSIDE COMPOUND, AND METHOD FOR PRODUCING 4'-ETHYNYL D4T AND ANALOGUE COMPOUNDS THEREOF | Nissan Chemical Industries, Ltd. (JP) | 2012-12-26 | — | — | EP | disclosed |
| EP-2537851-A1 | PROCESS FOR PREPARATION OF B-GLYCOSIDE COMPOUNDS | Nissan Chemical Industries, Ltd. (JP) | 2012-12-26 | — | — | EP | disclosed |
| US-20120322995-A1 | beta-DIHYDROFURAN DERIVING COMPOUND, METHOD FOR PRODUCING beta-DIHYDROFURAN DERIVING COMPOUND OR beta-TETRAHYDROFURAN DERIVING COMPOUND, beta-GLYCOSIDE COMPOUND, METHOD FOR PRODUCING beta GLYCOSIDE COMPOUND, AND METHOD FOR PRODUCING 4'-ETHYNYL D4T AND ANALOGUE COMPOUNDS THEREOF | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-12-20 | — | — | US | disclosed |
| US-20120322995-A1 | beta-DIHYDROFURAN DERIVING COMPOUND, METHOD FOR PRODUCING beta-DIHYDROFURAN DERIVING COMPOUND OR beta-TETRAHYDROFURAN DERIVING COMPOUND, beta-GLYCOSIDE COMPOUND, METHOD FOR PRODUCING beta GLYCOSIDE COMPOUND, AND METHOD FOR PRODUCING 4'-ETHYNYL D4T AND ANALOGUE COMPOUNDS THEREOF | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-12-20 | — | — | US | disclosed |
| US-20120309958-A1 | PROCESS FOR PREPARATION OF B-GLYCOSIDE COMPOUNDS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-12-06 | — | — | US | disclosed |
| US-20100280235-A1 | METHOD FOR PRODUCING 4'ETHYNYL d4T | ONCOLYS BIOPHARMA, INC (JP) | 2010-11-04 | — | — | US | disclosed |
| US-20100280235-A1 | METHOD FOR PRODUCING 4'ETHYNYL d4T | ONCOLYS BIOPHARMA, INC (JP) | 2010-11-04 | — | — | US | disclosed |
| EP-2228373-A1 | METHOD FOR PRODUCING 4'-ETHYNYL d4T | Oncolys BioPharma, Inc. (JP) | 2010-09-15 | — | — | EP | disclosed |
| WO-2009084655-A1 | METHOD FOR PRODUCING 4'-ETHYNYL d4T | ONCOLYS BIOPHARMA INC. (JP) | 2009-07-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100280235-A1 | METHOD FOR PRODUCING 4'ETHYNYL d4T | TYMS, DTYMK, DERA | NLRP3 4711/4885NFKB1 2704/4885NFKB2 2771/4885 |
| US-20120322995-A1 | beta-DIHYDROFURAN DERIVING COMPOUND, METHOD FOR PRODUCING beta-DIHYDROFURAN DERIVING COMPOUND OR beta-TETRAHYDROFURAN DERIVING COMPOUND, beta-GLYCOSIDE COMPOUND, METHOD FOR PRODUCING beta GLYCOSIDE COMPOUND, AND METHOD FOR PRODUCING 4'-ETHYNYL D4T AND ANALOGUE COMPOUNDS THEREOF | DHPS, B4GALT1, STT3A | NLRP3 2062/4885NFKB1 3301/4885NFKB2 2924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.